IP Library Granted Patent US 9,895,539
Granted Patent B1
US 9,895,539 · App. 14/300,193 · Granted Feb 20, 2018

Methods and systems for disease treatment using electrical stimulation

Inventors: Gary Heit (Woodside, CA); Bradford Evan Gliner (Sammamish, WA)
Assignee: Nevro Corp.
A61N1/36071A61N1/36157A61N1/36171A61N1/36175
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,895,539
App. No.
14/300,193
Granted
Feb 20, 2018
Kind
B1
Abstract

Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz.

Claims (41)

1. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient's central nervous system;

applying the electrical therapy signal to the target neural population located in the patient's central nervous system, wherein the electrical therapy signal

produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

2. The method of claim 1 wherein the changes reduce chronic pain in the patient.

3. The method of claim 1 wherein the changes include a change in a conductance of the fast sodium channel.

4. The method of claim 1 wherein the changes include a downregulation of the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

5. The method of claim 1 wherein the changes includes an attenuation of pathology-induced sodium channel activity.

6. The method of claim 1 wherein the changes include a normalization of pathological neural networks associated with fast sodium channel activity, expression, or both.

7. The method of claim 1 wherein the changes include a modulation of glial neuronal cell interaction.

8. The method of claim 1 wherein the changes include a reduction of glial cell activity by reducing an extracellular potassium level.

9. The method of claim 1 wherein a frequency of the electrical therapy signal affects NaV1.8, NaV1.9, or both NaV1.8 and NaV1.9 sodium channels over another, slower sodium channel.

10. The method of claim 9 , further comprising applying the therapy signal to increase an activity, expression, or both activity and expression of the slower sodium channel.

11. The method of claim 10 wherein the slower sodium channel includes a NaV1.3 channel.

12. The method of claim 1 wherein said changes include a decrease in a release, by glial cells, of at least one of nitric oxide, a proinflammatory cytokine, an excitatory amino acids, or a prostaglandin.

13. The method of claim 1 wherein the target neural population is at the patient's spinal cord.

14. The method of claim 1 wherein the target neural population is at a peripheral nerve of the patient.

15. The method of claim 1 wherein the changes include an increase in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

16. The method of claim 1 wherein the changes include a decrease in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

17. The method of claim 1 wherein the electrical therapy signal has a pulse width in a pulse width range of 10 microseconds to 333 microseconds.

18. The method of claim 1 wherein the electrical therapy signal has an amplitude in an amplitude range of 0.1 mA to 20 mA.

19. The method of claim 1 wherein the electrical therapy signal has a duty cycle in a duty cycle range of 5% to 75%.

20. The method of claim 1 wherein the electrical signal has a pulse width in a pulse width range of 10 microseconds to 333 microseconds and an amplitude in an amplitude range of 0.1 mA to 20 mA.

21. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz, a pulse width in a pulse width range of 10 microseconds to 333 microseconds and an amplitude in an amplitude range of 0.1 mA to 20 mA;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient's central nervous system;

applying the electrical therapy signal to the target neural population located in the patient's central nervous system, wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient, and wherein the electrical therapy signal treats chronic pain.

22. The method of claim 21 wherein the electrical therapy treats chronic back pain and wherein the target neural population is at a thoracic vertebral level.

23. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a pulse width in a pulse width range of 10 microseconds to 333 microseconds;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient's central nervous system;

applying the electrical therapy signal to the target neural population located in the patient's central nervous system, wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

24. The method of claim 23 wherein the changes produced by the electrical therapy signal reduce chronic pain in the patient.

25. The method of claim 23 wherein a frequency of the electrical therapy signal is in a range of 1.5 kHz to 100 kHz.

26. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient's central nervous system; and

applying the electrical therapy signal to the target neural population,

wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient, and

wherein the target neural population is remote from the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NAME PREVIOUSLY RECORDED ON REEL 033892 FRAME 0066. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 20, 2017
From: HEIT, GARY; GLINER, BRADFORD EVAN
To: NEVRO CORP.
Reel/Frame 041453/0206 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC
Reel/Frame 039002/0761 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2014
From: HEIT, GARY; GLINER, BRADFORD EVAN
To: NEVRO CORPORATION
Reel/Frame 033892/0066 →
Continuity (1)
Provisional Application 61833392 · Jun 10, 2013